NEW YORK, April 23 – Transgenomic has sold its Wave genetic analysis system to biotechnology giant Genzyme, the companies said Monday.

Genzyme will use the system in its research on genetic mutations that cause or are associated with hereditary diseases such as lysosomal storage disorders and some cancers. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.